Bevacizumab: a safe and effective treatment in a patient with advanced colorectal cancer and repeated removal of metastases.
Anticancer Drugs
; 20 Spec No 1: S7-S10, 2009 Apr.
Article
en En
| MEDLINE
| ID: mdl-19352110
ABSTRACT
Bevacizumab has been shown to be effective combined with chemotherapy for first-line treatment of advanced colorectal cancer, but little information is available about its efficacy and safety in patients who may be candidates for surgery at any time during the disease. The case history of a female patient with colorectal cancer, undergoing surgery for liver metastases and bilateral surgery for lung metastases at different time-points during her disease, is reported. Perioperative bevacizumab administration caused no complications either associated with surgery, in the early postoperative period, or in the subsequent months.
Buscar en Google
Bases de datos:
MEDLINE
Idioma:
En
Revista:
Anticancer Drugs
Asunto de la revista:
ANTINEOPLASICOS
Año:
2009
Tipo del documento:
Article
País de afiliación:
España